National Security Commission on Emerging Biotechnology

The National Security Commission on Emerging Biotechnology (NSCEB) is an American bipartisan legislative commission created by Congress in the National Defense Authorization Act for Fiscal Year 2022 (Sec. 1091).

The National Security Commission on Emerging Biotechnology is charged with conducting a thorough review of how advances in emerging biotechnology and related technologies will shape current and future activities of the U.S. Department of Defense, providing an interim report to the President of the United States and the Armed Services Committees within one year, and submitting a final unclassified report within two years to the President and the committees, including recommendations for action by Congress and the federal government.

The National Security Commission on Emerging Biotechnology was announced in March 2022 and will issue a final report to Congress by December 2024.

Commissioners
The NSCEB is composed of 12 appointed commissioners:


 * Dr. Jason Kelly, Chair - Co-Founder and CEO of Ginkgo Bioworks
 * Dr. Michelle Rozo, Vice Chair
 * Senator Alex Padilla (D-CA)
 * Senator Todd Young (R-IN)
 * Representative Stephanie Bice (R-OK)
 * Representative Ro Khanna (D-CA)
 * The Honorable Dov S. Zakheim - former Under Secretary of Defense (Comptroller)
 * Mr. Paul Arcangeli
 * Dr. Alexander Titus - VP of Strategy at Colossal Biosciences and former Assistant Director for Biotechnology in the Office of the Under Secretary of Defense for Research and Engineering
 * Dr. Eric Schmidt - Billionaire philanthropist and former CEO of Google
 * Dr. Angela Belcher
 * Ms. Dawn Meyerriecks

Reports
The Commission submitted its first report to Congress in December 2023 which included policy recommendations related to agricultural policy for potential inclusion in the Farm Bill.

In January 2024, the Commission released white papers regarding the convergence of artificial intelligence and biotechnology, or "AIxBio."

The Commission's final report is due to Congress in December 2024.